Our purpose was to investigate longitudinally healthrelated quality of life (HRQOL) outcomes and related factors up to 2 years post-pediatric SCT. A total of 99 mothers of patients, aged 1.5-17 years, completed two standardized HRQOL questionnaires, generic and disease specific (DS), about the child, and reported on their own symptoms of depression and family function pre-SCT, 12 and 24 months post-SCT. Clinical (diagnosis, radiation), child (age) and family (maternal depression) information was also obtained. Significant improvement in physical and psychosocial HRQOL from pre-SCT to 1 or 2 years post-SCT was reported. Survivors of ALL were reported to have poorer physical and psychosocial HRQOL than survivors of solid tumors on the DS measure. Maternal depression was negatively associated with physical and psychosocial HRQOL. Maternal education (higher) at pre-SCT predicted improvements in physical domains 2 years post-SCT; mother's age (older) and child's age (younger) also predicted improvements of physical and emotional HRQOL. We conclude that survivors of pediatric SCT improved physical and psychosocial HRQOL by 1 and 2 years post-SCT. Older survivors whose mothers are younger and distressed, with lower education at SCT have compromised HRQOL compared to other survivors. This study has important implications for the care of SCT survivors and their families.
Introduction
It is now well established that pediatric blood transplant protocols, including BM and SCT, are aggressive yet lifesaving procedures for children with cancer, blood and metabolic disorders. Unfortunately, this most frequent pediatric transplant is still associated with high mortality and morbidity. 1, 2 Given ongoing medical advances of the procedure, concerns remain regarding reduced healthrelated quality of life (HRQOL) connected to the original disease and treatment and SCT complications, [3] [4] [5] in spite of the relatively extensive literature in the field. The main objective of this study was to investigate longitudinally, pre-SCT, 1 and 2 years post-SCT, the HRQOL of pediatric survivors of SCT and related factors.
HRQOL is a subjective and multidimensional construct embraced by the World Health Organization that includes physical, psychological and social domains. Measuring HRQOL in children survivors of SCT may guide treatment decisions and serve as the basis for comprehensive intervention programs. 6 Some investigators have used generic measures to assess HRQOL in survivors compared to healthy peers, which is useful given that survivors interact with healthy peers when they reintegrate into their community. 7 Others have used disease-specific (DS) instruments that are valuable in determining the impact of disease and treatment on survivors' daily life. 7 There are two recent reviews of the literature in HRQOL of pediatric SCT survivors. 5, 8 The first review concluded that although most studies report adequate HRQOL, methodological differences across studies (type of instrument (generic vs DS), time of assessment after SCT and study design) and limited longitudinal studies question the validity of this conclusion. 8 The most recent review also identified the need for longitudinal research with this population and acknowledged the need to further examine the contribution of family factors to HRQOL. 5 Both of these gaps are addressed in this current study.
Before SCT, the HRQOL of most children is already compromised. 4, 9 Children who have been treated for ALL present with significantly poorer HRQOL than do children with solid tumors and other blood disorders, 10 likely because they and their families have already endured years of aggressive treatment and severe stress. 11 The SCT may place these children at additional risk for poor HRQOL. Children's HRQOL has been reported to be generally poor following the SCT but to improve by 4-6 months post-SCT; 3, 4, 12, 13 and even 12 months post-SCT. 1, 3 However, lower physical, emotional and social scores, higher bodily pain, and lower general health and self-esteem scores have been reported in SCT survivors than healthy norms. [14] [15] [16] [17] [18] Compared to their siblings, survivors were reported to have worse physical HRQOL but equivalent psychosocial HRQOL 2 years post-SCT. 19 Still, others have reported that survivors' HRQOL is within normal range by 3 or more years post-SCT even though they still report lower scores for general health and self-esteem than normative values. 20 Age at pre-SCT has been considered an important determinant of HRQOL. For example, at pre-SCT, adolescents' HRQOL was reported to be worse than children's. 10 Also, after the SCT and 1-year post-SCT better HRQOL was reported for younger (o6 years) than for older children 3, 4 but others have reported no age differences. 15, 21, 22 Moreover, low socioeconomic status (SES), 4 maternal anxiety and depression, and poor family function have been associated with poorer HRQOL 6 and 12 months post-SCT. 9, 23 Thus, contextual and familial factors that might contribute to HRQOL over and above the disease and treatment still need further investigation.
Most studies in this field have been atheoretical. We have adapted Wallander and Varni's 24 stress-coping multivariate conceptual model for understanding the impact of childhood chronic illnesses on the child's psychological adjustment, the effect of childhood cancer on children 25 and parents 26 and, more recently, the effect of previous disease and SCT on the child's cognitive, educational and visual motor functioning. 27 This model postulates that some child characteristics (age) and familial factors (maternal distress) would contribute to the outcomes of survivors over and above the effects of disease and treatment either as risk or as resilience factors. This model and the current literature guided the aims of the current study: (1) to describe longitudinally the HRQOL of survivors of pediatric SCT before, 1 and 2 years post-SCT using DS and generic instruments; and (2) to identify clinical, personal and familial factors that might be related to HRQOL in general and factors at pre-SCT that might be associated with HRQOL 2 years post-SCT.
Methods

Participants and recruitment
This study is part of a larger longitudinal project investigating the psychosocial and quality of life outcomes of children who undergo SCT and their families. The method has been described in greater detail elsewhere. 19, 27 Briefly, 120 (90.3%) of 133 eligible families from 1999 to 2003 agreed to participate; 17 (15%) were subsequently unable to enroll due to scheduling conflicts or the child's health. Of the remaining 103, 99 mothers completed measures at pre-SCT, 49 at 1 year and 48 at 2 years post-SCT. The primary reason for missing data was the child's death and poor health. This attrition rate is not uncommon with this population. [26] [27] [28] Procedure and outcome measures Approval from the research ethics board was obtained. Before completing initial assessment, informed consent was given by the primary caregiver, the mother in 98% of the cases, within a week of the transplant. Although currently there are numerous generic 3, 29 and DS measures 4,30-33 for assessing HRQOL in survivors of SCT, that was not the case when the study began, in the late 1990s. We used the Child Health Questionnaire (CHQ-PF50) 29 (generic) and the Pediatric Oncology Quality of Life Scale (POQOLS) 30 (cancer-specific) measures. The pre-SCT measures were completed as soon as the child was admitted for conditioning. Effort was made to have the assessments completed when the child was feeling relatively well. About 43% of families completed the assessment 2 weeks before transplant and 57% within 1 week of the procedure. The CHQ-PF50 is a 50-item parent-report version, wellvalidated measure used across diverse groups of children with various health conditions. It provides two summary scores, physical and psychosocial, and several subscales. The two summary scores were used in this study; higher scores indicate better HRQOL. The POQOLS is a 21-item parent-completed measure designed for assessing quality of life of children with cancer. It assesses overall HRQOL (POQOL total), physical well-being (POQOL physical), role restriction by disease (POQOL restriction) and emotional well-being (POQOL emotional). Good internal consistency (r ¼ 0.67 and 0.87) and inter-rater reliability (r ¼ 0.89) were reported for the total and each factor. High scores indicate worse HRQOL. Both the generic and DS HRQOL measures were designed based on a multivariate concept of health, which is consistent with the conceptual model of the study.
Measures of related factors
The clinical variables considered in this study were obtained from the medical chart: diagnosis type (ALL, other leukemias, neuroblastoma, other tumors and hematological disorders); time since diagnosis at pre-SCT (less than 6 months, between 6 months and 1 year, and more than 1 year at pre-SCT); radiation group (cranial radiation treatment (CRT) before SCT, total body radiation (TBR) only, combined CRT and TBR, and no radiation); GVHD (none and limited and extensive, combined for analysis, as determined by an experienced hematologist in the transplant unit with reliability greater than 90%).
The Family Adaptability and Cohesion Evaluation Scale 34 (FACES-III) and the Beck Depression Inventory 35 (BDI) were used as the measures of family cohesion and maternal distress, respectively. These measures were chosen because they are brief and widely used in families with childhood chronic illness or cancer. These measures were completed at each assessment point. FACES-III is a 20-item scale with two dimensions of family relations: adaptation and cohesion. It has good test-retest reliability (r ¼ 0.80 for adaptability, and r ¼ 0.83 for cohesion) and high discriminative validity. 36 We used cohesion as a measure of family functioning. The BDI is a selfadministered 21-item measure of depressive symptomatology. The BDI has been found to be highly sensitive in measuring change in symptoms and severity. 37 Concurrent validity of the BDI with most other self-report measures of depression has been consistently high. 37 The child characteristics used for analysis were age pre-SCT and gender. Mother's age and education pre-SCT were also included.
Statistic analyses
The statistical software SAS version 9.1 (SAS Institute Inc., Cary, NC, USA) was used for analysis. Statistical analyses were similar to those conducted with cognitive outcomes in a previous study. 27 Descriptive statistics were calculated for the outcome variables and covariates of interest. Bivariate analyses were conducted for the HRQOL outcomes (CHQ physical and psychosocial summary scores; POQOL total and physical, restriction and emotional scores) at each assessment, and clinical, child's and familial factors to reduce the number of variables for subsequent regression analyses. w 2 -tests within categorical predictors, analysis of variance for continuous and categorical and correlation analyses for continuous variables were conducted to avoid collinearity between variables. Covariates significant at the 20% level in the bivariate analyses were included in the multivariable analyses. The linear mixed model multiple regression analyses allowed for repeated measures with a compound symmetry covariance structure to examine the longitudinal effect of time and potential predictors (disease and treatment factors, child characteristics and familial factors), controlling for the effects of each factor. If there was a time effect, linear contrast analysis was conducted for comparisons across time. All factors were entered into each regression model simultaneously. This model makes optimal use of all available data at each assessment time. Pair-wise analysis was conducted for post hoc multiple comparisons using Tukey-Kramer's adjustment. Finally, to determine clinical significance, effect sizes were calculated. On the basis of Norman, Sloan and Wyrwich's 38 recommendations, an effect size of 0.5 was considered of clinical significance. Table 1 presents the descriptive statistics of the characteristics of the sample and the clinical variables. Briefly, children's mean age at pre-SCT was 8.27 years (s.d. ¼ 4.38). The largest diagnostic subgroup before SCT was ALL with 46%. Seventy-four percent of the children were scheduled for an allogeneic transplant. Fifty percent of the sample did not have primary cranial radiation as part of their previous treatment or TBR as part of the conditioning in preparation for the transplant. The mean time since diagnosis at pre-SCT was 19.45 months (s.d. ¼ 23.74). Most children came from a two-parent Caucasian family and a middleclass socioeconomic background. 39 A comparison of pre-SCT data of participants who completed follow-up assessments and those who only participated at pre-SCT using pre-SCT data yielded no significant differences in any of the variables except for the total POQOL scores (means of 72.22 and 81.61; t97 ¼ 2.56, Po0.01), indicating better scores at pre-SCT for those who continued in the study than those who did not. Table 2 presents the means and standard deviations of the outcome measures at each assessment and the statistical results of time effects. Although the results ranged widely across participants at each assessment point, there were Factors associated with physical HRQOL outcomes over time Bivariate analyses between physical CHQ and clinical factors (time since diagnosis, diagnosis, cranial radiation group and GVHD), familial factors (maternal age and education, maternal symptoms of depression and family cohesion) and child characteristics (age at pre-SCT and gender) only identified maternal depression scores as a potential predictor of physical CHQ, and time since diagnosis, diagnosis and cranial radiation group as potential predictors for physical POQOL of the DS measure of HRQOL. Subsequent mixed model analyses indicate that maternal depression scores were significantly and strongly associated with the physical CHQ (F1,110 ¼ 10.01, P ¼ 0.0020) and POQOL (F1,119 ¼ 8.30, P ¼ 0.0047) scores. Thus, children whose mothers had high depression scores were rated as having poorer physical HRQOL as assessed by both measures. The physical POQOL score was also associated with diagnosis (F4,54 ¼ 3.72, P ¼ 0.0095). Adjusted post hoc paired-wise comparisons indicated that survivors of ALL were rated as having significantly worse physical HRQOL than survivors of other solid tumors (t73 ¼ 3.25, P ¼ 0.0162; ES ¼ 0.74), a medium to large effect. Survivors of blood disorders were also rated worse than survivors of other solid tumors (t49 ¼ 3.27, P ¼ 0.0155; ES ¼ 0.34), though the effect size was small.
Results
Preliminary analyses
Longitudinal changes in HRQOL
Factors associated with psychosocial HRQOL outcomes over time
Bivariate correlations between CHQ psychosocial scores and potential-related factors identified diagnosis and maternal depression scores as potential predictors. In subsequent mixed model regression analyses, only maternal depression scores (F1,105 ¼ 30.68, Po0.0001) were found to be significantly associated with CHQ psychosocial scores, with higher maternal depression scores being associated with lower psychosocial scores.
For the emotional POQOL scores of the DS measure, bivariate analyses identified time since diagnosis, diagnosis, cranial radiation group and maternal depression scores as potential predictors. In subsequent mixed model regression analyses, diagnosis (F4,77 ¼ 2.96, P ¼ 0.0248), time since diagnosis (F1,59 ¼ 4.77, P ¼ 0.0330) and maternal depression scores (F1,174 ¼ 27.86, Po0.0001) were found to be significantly associated with emotional POQOL scores. Tukey-Kramer's adjustment for post hoc multiple comparisons indicated that survivors of ALL were rated as having significantly worse emotional HRQOL than survivors of Table 2 Means and standard deviations of HRQOL outcomes at pre-SCT, 1-year and 2-year post-SCT Factors at pre-SCT associated with HRQOL outcomes at 2 years post-SCT To assess what factors at pre-SCT would predict HRQOL outcomes at 2 years post-SCT, we used data from only those patients who survived and participated in the last assessment. Preliminary analyses of the difference between the pre-SCT scores and the 2 years post-SCT scores yielded strongly significant improvements for each outcome measure as were expected, given the longitudinal results described above (Po0.0001 for each physical CHQ, POQOL total, POQOL physical and restriction factors, and P ¼ 0.0018 and 0.0026 for POQOL emotional and psychosocial CHQ, respectively). Then, we conducted bivariate analyses with the difference score (post-SCT scoreÀpre-SCT score) for each outcome and potential predictors at pre-SCT, followed by mixed model regression analyses to examine what disease/treatment, familial or personal factors at pre-SCT may be associated with improvement in HRQOL 2 years post-SCT.
Global HRQOL. Bivariate analyses between the difference score and potential predictors of total POQOL identified maternal age and education, and child's age as potential predictors. Mixed model regression analyses indicated that only maternal education (F2,40 ¼ 4.85, P ¼ 0.013) and maternal age (F1,40 ¼ 4.18, Po0.048) were significantly associated with improvement of survivors' overall HRQOL, with older mothers and those with higher education reporting greater improvement 2 years post-SCT.
Physical HRQOL. Bivariate analyses between the difference in the physical CHQ scores and potential predictors identified GVHD as a potential predictor of the physical CHQ improvement over time but the regression analyses showed the effect was borderline (F1,39 ¼ 3.19, P ¼ 0.088), suggesting a trend indicating that survivors who did not develop GVHD were reported to have greater improvement in physical HRQOL. Bivariate analyses for the physical POQOL scores identified mother's age and education, and child's age as potential predictors. Mixed model regression analyses indicated that maternal age (F1,38 ¼ 4.05, P ¼ 0.051) and education (F2,38 ¼ 4.73, P ¼ 0.014) were significantly associated with physical POQOL. Children of older mothers at SCT with university education were reported to have better physical scores 2 years post-SCT compared to children of younger mothers with lower education (t41 ¼ 2.01, P ¼ 0.051; ES ¼ 0.31; t41 ¼ 2.97, P ¼ 0.0051; ES ¼ 0.46, for maternal age and education, respectively), with medium to small effects.
Psychosocial HRQOL. Bivariate analyses between the difference score for the psychosocial CHQ and potential predictors identified only family cohesion as a possible predictor, which did not reach significance in the regression analyses. Bivariate analyses between the difference score for the emotional POQOL factor identified time since diagnosis, maternal education and age, and child's age as potential predictors. The following mixed model regression analyses indicated that emotional POQOL scores were significantly associated with only child's age (F1,40 ¼ 6.07, P ¼ 0.018; ES ¼ 0.38), with a small effect, suggesting that the younger the child at pre-SCT, the greater the emotional HRQOL improvement. Finally, bivariate analyses also identified maternal education as a potential predictor, which was confirmed in the regression analyses. Thus, restriction POQOL scores were significantly associated with maternal education (F1,39 ¼ 4.83, P ¼ 0.013), with the greatest improvement in HRQOL related to medical restriction, and a medium effect size, in children whose mothers completed university education (t39 ¼ 2.95, P ¼ 0.005; ES ¼ 0.46).
Discussion
Survivors of pediatric SCT showed improvement of physical and psychosocial HRQOL 1 and 2 years post-SCT, as reported by mothers in generic and DS instruments. Because there were no significant changes in HRQOL from 1 to 2 years, we can conclude that the major improvement took place by 1-year post-SCT. This longitudinal finding is consistent with previously reported patterns of improvement of HRQOL by us and by others 6 months, 4,9 1 year or even a wide range period post-SCT, 16, [40] [41] [42] [43] [44] on primarily cross-sectional studies. More importantly, however, the current study expanded knowledge to better understand the impact of disease and treatment on survivors' HRQOL by identifying risk and resistance factors that may be related to survivors' HRQOL 1 and 2 years post-SCT. These findings support the multivariate conceptual model, which we have adapted from Wallander and Varni, 24 for psychosocial adjustment (and HRQOL) to chronic illness. Using the DS measure in this study, we found that a diagnosis of ALL was the best disease factor predictor of poorer physical and emotional HRQOL outcomes 1 and 2 years post-SCT. This finding confirms our previous findings that children with ALL and neuroblastoma were reported to have the worse HRQOL before SCT. 10 Children with ALL who survive SCT had endured high-risk medical regimens before being considered candidates for SCT and in preparation for the SCT. They have experienced recurrence of disease and uncertainty about the future for many years. Thus, this finding may be unique to children with ALL who undergo SCT as compared to survivors of ALL who may not experience as much uncertainty about their survival and whose HRQOL had not been found to be different from that of survivors of other childhood cancer. 45, 46 Moreover, our findings suggest that the cost of their survival is still evident 2 years post-SCT in their poorer HRQOL compared to other SCT survivors.
None of the other disease/treatment variables (for example, history of cranial radiation, type of transplant, GVHD) were associated with physical HRQOL or psychosocial HRQOL, except for time since diagnosis at SCT. As we might expect, those survivors who have been under a treatment protocol the longest, and likely had experienced disease recurrence, were reported to have the worse emotional HRQOL, suggesting that the cumulative chronicity of compromised health is a risk factor for emotional well-being of pediatric SCT survivors.
Within the multivariate conceptual model, familial factors at pre-SCT, maternal age and education, and maternal symptoms of depression seem to be the best predictors of HRQOL of SCT survivors 2 years post-SCT. These results confirm our previous findings on HRQOL 6 months post-SCT and on cognitive and educational outcomes with this population, 27 1 and 2 years post-SCT. These combined results suggest that the home environment is important not only for cognitive and educational outcomes, but also for HRQOL outcomes of pediatric SCT survivors. Using low maternal education as an index of low SES, this study confirms the adverse effect of low SES. 4 These findings combined may reflect the quality of maternal involvement in the child's care and support the assumption that high maternal age and education and low maternal distress may serve to protect survivors of the long-term adverse effects of disease and demanding medical treatment. Although maternal distress, measured by symptoms of depression, emerged as a risk factor negatively associated with physical and psychosocial HRQOL of SCT survivors, it is possible that mothers with more symptoms of depression reported more negatively about their children's HRQOL as a reflection of their emotional well-being rather than their children's.
Finally, consistent with previous report with this population, 3, 4 being younger (preschooler) at pre-SCT seems to be a child's characteristic that serves as a protective factor for emotional HRQOL at 2 years post-SCT. This finding may reflect the fact that younger children might have less recollection of their difficult experience before and particularly during the difficult weeks following the SCT procedure.
There are several limitations with this study. In our effort to reduce research burden on seriously ill children, we only obtained proxy maternal reports of the child's HRQOL. Proxy CHQ was also successfully used in a large study of childhood cancer survivors. 47 Parental reports of child's HRQOL tend to be worse than self-reports, 48 and the association between maternal distress and HRQOL may reflect the mother's own distress. Thus, reports from the child and other informants may clarify the validity of these reports. The consistent information across generic and DS measures, however, strengthened the validity of findings. This study exemplifies the major challenges of longitudinal research with severely ill children treated for rare and life-threatening diseases. The relatively small sample that remained in this longitudinal study, likely limited the power of the statistical analyses, reducing the possibility of identifying other potential-related factors. On the other hand, the small sample made the results conservative.
Despite these limitations, based on maternal reports on generic and DS measures of HRQOL, the findings of this study provide a comprehensive and longitudinal examination of the HRQOL outcomes and related risk and protective factors for survivors of pediatric SCT. Although survivors, as a group, improved their physical and psychosocial HRQOL by 1 and 2 years post-SCT, analysis of clinical variables, child characteristics as well as familial factors identified some subgroup of survivors at risk for poor physical and psychosocial HRQOL. These subgroups included those who were treated for ALL before SCT, who were diagnosed at an older age, whose mothers were young and had limited education and whose mothers had symptoms of depression. These findings have important implications for treatment planning and for developing psychosocial prevention and intervention programs with a family focus to ensure that the identified at-risk subgroups receive the assistance necessary for achieving better HRQOL after pediatric SCT.
